Portfolio News| June 2021
Spectrum Exits Verisys to Stone Point Capital
South Jordan, UT - Verisys Corporation and Aperture Health have been acquired and combined by funds managed by Stone Point Capital.
“The combined company establishes a market leader in the credentialing, enrollment, and provider data management space that can provide an exceptional level of service, security, and scalability,” said Stone Point CEO Chuck Davis. “We’re looking forward to leveraging our network within the managed care and workforce risk management industries to support the company’s next phase of growth.”
The combined organization brings together leaders of respected and recognized companies. John Benson, formerly CEO at Verisys, has assumed the role of Chairman. Charlie Falcone, formerly CEO of Aperture Health, has assumed the role of CEO.
“The merger of Aperture and Verisys simply makes sense,” said Verisys’ Benson. “Our technologies and services perform similar work in different markets. Combining helps us serve many of the major players in the healthcare industry, including hospital systems, health plans, retail pharmacies, pharmaceutical companies, telehealth providers, and state Medicaid agencies.”
Along with the comprehensiveness of the combined offerings, the cultural fit between the two companies attracted Aperture’s Falcone. “Verisys and Aperture have proven track records of excellence, integrity, and transparency with employees and clients,” he said. “This combination will accelerate our ability to help our clients fix the many problems associated with siloed and inaccurate provider data. We’re excited about our future and look forward to transforming healthcare together.”
Leverage Health will remain an active investor in the combined company. Aperture was represented by Bailey Southwell & Co., and Verisys was represented by Stifel.
About Verisys Corporation
Verisys provides a comprehensive cloud-based technology platform of data, analytics, and services that supports enterprise-wide compliance in the U.S. healthcare industry. Verisys protects healthcare consumers by enforcing competency and regulatory compliance, system integrity, and patient safety through transparency. Verisys verifies credentials and screens and monitors millions of healthcare providers annually across all sectors of the healthcare economy. For nearly 30 years, Verisys has developed and implemented highly secure technology solutions for some of the largest healthcare delivery and support organizations in the country. Verisys is an NCQA-certified and URAC-accredited Credentials Verification Organization. For more information, please visit verisys.com.
About Aperture Health
Aperture Health makes comprehensive provider data management easy. We help health plans, health systems, and state Medicaid agencies improve provider data quality, build and manage provider networks, and publish and maintain provider directories. Our transformative technology has made us the largest outsourced credentials verification organization in the United States. And because we’ve delivered provider data programs to the most complex healthcare organizations for more than two decades, we have the experience to maximize performance, no matter the challenge. Visit aperture.health to learn how we simplify network administration.
Content contained in this blog post is not intended to and does not constitute investment advice. Your use of the information in this blog post and materials linked is at your own risk. Spectrum Equity does not make any guarantee or other promise as to any results that may be obtained from using this content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is not indicative of future results, and there is a possibility of loss in connection with an investment in any Spectrum Fund. To the maximum extent permitted by law, Spectrum Equity disclaims any and all liability in the event any information, commentary, analysis, and/or opinions prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The specific companies identified above does not represent all of Spectrum’s investments, and no assumptions should be made that any investments identified were or will be profitable.